NCT00487994 Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia Status COMPLETED Phase PHASE3
NCT00481364 Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients Status COMPLETED Phase PHASE3
NCT00469326 Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study Status COMPLETED Phase PHASE3
NCT00465088 An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) Status COMPLETED Phase PHASE3
NCT00449410 Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients Status COMPLETED Phase PHASE4
NCT00446940 Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C Status COMPLETED Phase PHASE2
NCT00441597 Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo? Status COMPLETED Phase PHASE4
NCT00437892 Statins to Reduce D-dimer Levels in Patients With Venous Thrombosis Status TERMINATED Phase PHASE2
NCT00435045 Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia Status COMPLETED Phase PHASE3
NCT00432354 An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus Status UNKNOWN Phase PHASE2/PHASE3
NCT00427960 Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg Status TERMINATED Phase PHASE4
NCT00418834 Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112) Status COMPLETED Phase PHASE3
NCT00414531 Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity Status COMPLETED Phase PHASE4
NCT00412841 Atorvastatin to Prevent Avascular Necrosis of Bone in Steroid Treated Exacerbated Systemic Lupus Erythematosus Status TERMINATED Phase PHASE2
NCT00411190 Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of Acetaminophen, Ibuprofen And Atorvastatin Status COMPLETED Phase PHASE1